Digital Point Solutions for Extending Contact Tracing Capacity
- PMID: 36150073
- PMCID: PMC10348610
- DOI: 10.1097/OLQ.0000000000001712
Digital Point Solutions for Extending Contact Tracing Capacity
Abstract
Background: Initial COVID-19 surges in the United States created a need for technology to supplement human resources to increase efficiency and efficacy.
Methods: Resolve to Save Lives worked with jurisdictions to co-design four technology solutions-Epi Viaduct data pipeline, Epi Contacts contact elicitation webform, Epi Locator contact information search plugin, and Epi Viewpoint case management system (CMS)-to expand the capacity of case investigation and contact tracing (CI/CT) teams. We assessed impact on reducing CI/CT time intervals for COVID-19 using product data and user feedback.
Results: Epi Viaduct accelerated the transfer of approximately 7,400,000 records from an electronic laboratory reporting system in a single jurisdiction to the respective CMS from more than 2.5 hours to less than 1 minute and reduced time to remove duplicate laboratory results from multiple days to less than 6 hours. Epi Contacts focused on increasing the efficacy of contact elicitation, and during a single period, 10% of index cases (9,440 of 96,319) completed Epi Contacts for a total of approximately 18,700 contacts elicited. User interviews indicated the tool increased speed of CI/CT workflows. In total, 134,410 searches were run in Epi Locator by 7320 distinct users-75% of which returned 1 or more person matches. A simple CMS, Epi Viewpoint, was developed and completed, but not deployed.
Conclusions: Systems to mount large-scale population-based contact tracing programs were developed and implemented during the COVID-19 pandemic and can be adapted for CI/CT programs aiming to control the spread of other communicable diseases such as sexually transmitted diseases.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Sexually Transmitted Diseases Association.
Conflict of interest statement
Conflict of Interest and Sources of Funding: None declared.
Figures
References
-
- Coronavirus in the U.S.: Latest Map and Case Count (The New York Times Web site). Available at: https://www.nytimes.com/interactive/2021/us/covid-cases.html. Accessed March 11, 2022.
-
- Reid M Enanoria W Stoltey J, et al. . The SARS-CoV-2 pandemic: The race to trace: contact tracing scale-up in San Francisco—early lessons learned. J Public Health Policy 2021; 42:211–221. Available at: https://www.ncbi.nlm.nih.gov/. Accessed March 11, 2022. - PMC - PubMed
-
- Banco E. Inside America's COVID-reporting breakdown (Politico Web site). Available at: https://www.politico.com/news/2021/08/15/inside-americas-covid-data-gap-.... Accessed March 11, 2022.
-
- Kretzschmar ME Rozhnova G Bootsma MCJ, et al. . Impact of delays on effectiveness of contact tracing strategies for COVID-19: A modelling study. Lancet Public Health 2020; 5:e452–e459. Available at: https://www.thelancet.com/. Accessed March 11, 2022. - PMC - PubMed
-
- Measures to Improve COVID-19 Response (Resolve to Save Lives Web site). Available at: https://preventepidemics.org/covid19/resources/measures-to-improve-covid.... Accessed February 23, 2022.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical